drugset / Trial / NCT02576860

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

NCT02576860

Phase 3 Completed 263 enrolled Maruho Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.

Timeline

Start
2015-10
Primary completion
2017-02-27
Completion
2017-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Omiganan Protein / enzyme biologic Topical

Indications